Drug
Eptinezumab Jjmr
Eptinezumab Jjmr: highest development phase Approved, developed by Lundbeck. 1 trial record tracked on RxWires.
- Highest phase
- Approved
- Developer
- Lundbeck
Trials
| Drug | Phase | Indication |
|---|---|---|
| VYEPTI | Approved |
Latest
No recent events.
Follow Eptinezumab Jjmr on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.